Scientific letter
Once weekly semaglutide and cardiovascular outcomes in patients with type 2 diabetes and heart failure with reduced left ventricular ejection fraction

Miguel A. Pérez-Velascoa ◊Alicia Trenasb ◊M. Rosa Bernal-Lópeza cMaría D. García de LucasaRicardo Gómez-Huelgasa c dLuis M. Pérez-Belmontea d e f

a Servicio de Medicina Interna, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain

b Servicio de Medicina Interna, Área Sanitaria Norte de Málaga, Hospital de Antequera, Antequera, Spain

c Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain

d Departamento de Medicina y Dermatología, Facultad de Medicina, Universidad de Málaga (UMA), Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain

e Servicio de Medicina Interna, Hospital Helicópteros Sanitarios, Marbella, Spain

f Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain

For the purchase of this article it is necessary to fill in the following form:

Name *

First name *

Last name *

Email *

Adress *

Number *

City *

Country *

Provincia *

Postal code *

Phone *

N.I.F. *

I wish to receive information about Elsevier products and special promotions by email

I wish to receive information about Elsevier partners' products and special promotions by email

Acepto la Privacy Policy y los Terms and conditions

Customer service

932 415 960

+34 932 415 960

Monday to Friday from 9am to 6pm (GMT+1) except for the months of July and August, which will be from 9am to 3pm.